Parkinson's disease (PD) is a neurodegenerative dis-animal model and the main issues that permeate the neural transplantation literature. order with onset occurring in middle to later life. It is named after the British physician Dr. James Parkinson,
In science, one of the more difficult decisions is the choice of the most appropriate experimental model. Over who wrote the classic monograph, Essay on the shaking palsy, in 1817. This work described the cardinal signs the years, a number of different models have been used to study this devastating disease. By far the most com-and symptoms of one of the most common neurological disorders in the Western world-resting tremor, cog-mon models are neurotoxin induced, of which the most popular are the hemiparkinsonian 6-hydroxydopamine wheel rigidity, bradykinesia, and postural instability. The basic neuropathology of the disease was established (6-OHDA) model in the rat and the 1-methyl-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model in the mouse. in the first two decades of the 20th century. It is still not known why the pigmented melanin-containing, dopa-6-OHDA is structurally similar to dopamine and is actively taken up into the cells. Once the toxin is internal-mine-producing neurons in the substantia nigra pars compacta undergo selective and progressive degenera-ized, it is metabolized, releasing free radicals that destroy the cell (1), producing a rapid, irreversible, and tion, resulting in severe secondary depletion of dopamine stores in the caudate and putamen (neostriatum). It almost complete destruction of the dopamine neurons (8). The MPTP is metabolized to MPP+, which in turn is estimated that depletion of total dopamine stores must exceed 50-75% before symptoms appear (7).
inhibits NADH coenzyme Q of complex I of the mitochondrial respiratory chain (4), depleting ATP and caus-In the last two decades, cell transplantation has been shown to be a promising approach for restoration of ing a loss of membrane potential and cell death. While MPTP produces parkinsonism in man and is therefore function in PD. The underlying hypothesis is that dopamine-producing cells implanted in the striatum will sub-felt to be a better model of the disease, its efficacy depends on the age and species of the animal (6). Even stitute for those mesencephalic dopamine neurons that have been lost as a consequence of the disease process.
within species, there is extensive variation between individuals, and the deficits may be transient (12) . Neural transplantation is only considered an option in cases in which L-dopa treatment is no longer effective.
Given the popularity of these models, it is not surprising that Dr. Triarhou uses them as a comparison to the This book, Dopaminergic Neuron Transplantation in the Weaver Mouse Model of Parkinson's Disease by weaver mouse model. However, there are other models that should be considered in this discussion. Salsolinol, Lazaros C. Triarhou, is written to convey to researchers in the field of neural transplantation in PD the utility of a dopamine-derived isoquinoline (10) , is taken up by dopamine terminals and retrogradely transported to the a neglected genetic mouse model, the weaver mouse, as a tool to study PD and neural transplantation. In this soma where it is oxidized into isoquinolinium and hydroxyl radicals. Rotenone, a common pesticide, is an-well-written volume, the author takes us on an organized tour of what is known about the weaver mouse and the other toxin that targets nigral dopamine neurons (3) and, unlike most other neurotoxins, is characterized by α-sy-PD-relevant research that has been conducted. From the introduction, which provides a brief synopsis of the nuclein inclusions and inhibition of mitochondrial complex I, as are seen in the disease. Further, the author does pathogenesis and treatment of the disease and the main experimental models used to study it, to the detailed dis-not adequately address how the weaver mouse model compares with other genetic mouse models of PD. There cussion of neural transplantation in subsequent chapters, this book provides a thorough review of the use of this are at least five genes [α-synuclein (PARK 1), parkin 90 BOOK REVIEW (PARK 2), UCH-L1 ubiquitin C-terminal hydroxylase issues that are addressed (early events after transplantation such as physiological cell death, availability of tro-L1 (PARK 5), DJ-1 (PARK 7), and NR4A2 (NURR 1)] that have been identified in familial PD (5). Each has phic factors, and localization of the cytokines) are issues that are common to the neural transplantation field in a different mode of inheritance and relatively different phenotypic presentation.
general, not just the weaver mouse model. For example, it is not yet clear if the progression of PD itself may In the second chapter of this book, Dr. Triarhou focuses on the biology and pathology of the weaver mu-adversely affect graft survival either directly or through lack of appropriate trophic support in the diseased stria-tant mouse. This is a genetic model of dopaminergic degeneration in which there is a spontaneous autosomal tum. Another idea suggested is the double grafting experiment to reconstruct the nigro-stiato-nigral pathway recessive mutation in the C57BL/6J mouse strain at the distal end of chromosome 16. This mutation causes a using DA cells and striatal cells. Recently, it was discovered that dual graft conditions improved behavioral re-single missense mutation in the gene that codes for the G-protein-activated inwardly rectifying potassium chan-covery compared with a single graft, and that sequential grafting can improve dopaminergic cell survival (2). nel (GIRK2) (11) . This single mutation leads to degeneration in the mesostriatal DA neurons and disturbed
In general, this mouse model can be useful and complementary to the other PD models. The disadvantage in neuronal organization in the cerebellar cortex. Dopaminergic neurons in the midbrain (substantia nigra, ventral this mouse model is the cerebellar element in the model, which partially masks the mesostriatal degeneration. The mesencephalon, and retrobubral area), telencephalic projection (striatum), hippocampus, and the granule cells of author has done a good job of presenting the history of research using the weaver mouse and relating these works the cerebellum die. The changes in DA cell number in the weaver substantia nigra occur in two phases, one by to other studies of neural transplantation. This book is a valuable resource covering important issues in neural 3 months of age and one during the second year of life. This chapter summarizes the previous studies of this transplantation. It will be particularly useful for young scientists new to this field. model using mosaic chimers, tissue cultures, and cerebellar grafts to determine the effect of the gene on dif-REFERENCES ferent phenotypic changes. The behavioral phenotype of the homozygous weaver mutant combines both ataxia the pattern of inheritance, onset of disease, and the se-
